The Meningococcal Disease Treatment Market encompasses a portfolio of vaccines, antibiotics and monoclonal antibody therapies designed to prevent or treat infections caused by Neisseria meningitidis. Conjugate and polysaccharide-protein vaccines offer broad protection across multiple serogroups, while novel adjuvants boost immunogenicity and durability of immune response. Antibiotic r... https://articlescad.com/meningococcal-disease-treatment-market-to-grow-on-rising-disease-incidence-168536.html